Europe excels in fundamental research, yet too few discoveries reach the market. Many promising projects stall in the “Valley of Death,” where resources, incentives, and support for technology maturation are limited. While spin-offs attract significant attention, they are not always the right path, especially within Europe’s fragmented and under-resourced innovation landscape.
This webinar series showcases practical private, public, and hybrid models that help biomedical projects overcome these hurdles and move more effectively toward commercialisation.
The next session is titled Industry open innovation programs for collaboration with academia and speakers are Jiri Keirsse, Head of Innovation Strategy & Public Private Partnerships at UCB, Belgium, and Toshal Patel, Head of Scouting and Partnering at UCB, Belgium.
More information about the session and speakers will be added soon.
Join our newsletter and get the latest news